LabTech(SH:688056)2025-02-25 09:15Financial Performance - The company achieved total operating revenue of 424.37 million RMB, a year-on-year increase of 2.01%[3] - Operating profit reached 45.24 million RMB, reflecting a significant growth of 58.92% compared to the previous year[3] - Net profit attributable to shareholders of the parent company was 39.71 million RMB, up 44.08% year-on-year[3] - The basic earnings per share increased to 0.59 RMB, representing a growth of 43.90%[3] - The overall gross profit margin improved, increasing by 1.85 percentage points year-on-year[8] Assets and Liabilities - Total assets at the end of the reporting period were 957.29 million RMB, a decrease of 4.70% from the beginning of the year[3] - The company plans to recognize an impairment loss of approximately 8 million RMB related to goodwill from the acquisition of CDS Analytical, LLC[9] Government Support - The company reported a government subsidy income increase of 3.43 million RMB compared to the previous year[9] Operational Improvements - The company has enhanced its product competitiveness through quality control and efficiency improvements in production[6] - The company has made positive progress in team building and new product development during the reporting period[6]